Treating diarrhoeal disease in children under five: The global picture

Archives of Disease in Childhood

Volumn 99, Issue 3, 2014, Pages 273-278

  Unger, Carla Chan ^a   Salam, Shumona Sharmin ^a   Sarker, Md Shafiqul Alam ^a   Black, Robert ^b   Cravioto, Alejandro ^c   Arifeen, Shams El ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMM CHILD HEALTH; EPIDEMIOLOGY; GENERAL PAEDIATRICS; INFECTIOUS DISEASES;

BICARBONATES; CHILD, PRESCHOOL; DIARRHEA; GLUCOSE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; POTASSIUM CHLORIDE; SODIUM CHLORIDE; ZINC;

EID: 84894104073     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304765     Document Type: Article

References (76)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379: 2151-61.
2. Bhutta ZA, Das JK, Walker N, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet 2013;381: 1414-29.
3. Podewils LJ, Mintz ED, Nataro JP, et al. Acute, infectious diarrhoea among children in developing countries. Semin Pediatr Infect Dis 2004;15: 155-68.
4. United Nations Children's Fund (UNICEF). Pneumonia and diarrhoea: tackling the deadliest diseases for the world's poorest children. New York: UNICEF, 2012.
5. Gerlin A. A Simple Solution. Time Magazine. 2006.
6. Winch PJ, Gilroy KE, Fischer Walker CL. Effect of HIV/AIDS and malaria on the context for introduction of zinc treatment and low-osmolarity ORS for childhood diarrhoea. J Health Popul Nutr 2008;26: 1-11.
7. Santosham M, Chandran A, Fitzwater S, et al. Progress and barriers for the control of diarrhoeal disease. Lancet 2010;376: 63-7.
8. Taylor CE, Greenough WB III. Control of diarrhoeal diseases. Annu Rev Public Health 1989;10: 221-44.
9. Water with sugar and salt. Lancet 1978;2: 300-01.
10. Munos MK, Walker CL, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol 2010;39: 75-87.
11. Chatterjee A, Mahalanabis D, Jalan KN, et al. Oral rehydration in infantile diarrhoea. Controlled trial of a low sodium glucose electrolyte solution. Arch Dis Child 1978;53: 284-9.
12. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhoea: a review. Am J Gastroenterol 2009;104: 2596-604.
13. Telmesani AM. Oral rehydration salts, zinc supplement and rota virus vaccine in the management of childhood acute diarrhoea. J Family Community Med 2010;17: 79-82.
14. Walker CL, Black RE. Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes. Int J Epidemiol 2010;39: 63-9.
15. Larson CP, Roy SK, Khan AI, et al. Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease. J Health Popul Nutr 2008;26: 356-65.
16. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhoea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999;135: 689-97.
17. Baqui AH, Black RE, El Arifeen S, et al. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ 2002;325: 1059-66.
18. Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. Am J Clin Nutr 2000;72: 1516-22.
19. Dutta P, Mitra U, Dutta S, et al. Zinc, vitamin A, and micronutrient supplementation in children with diarrhoea: a randomised controlled clinical trial of combination therapy versus monotherapy. J Pediatr 2011;159: 633-7.
20. Fischer Walker CL, Black RE. Micronutrients and Diarrhoeal Disease. Clin Infect Dis 2007;45(Suppl):S73-7.
21. Milner K, Fuchs G. What micronutrient supplements in persistent diarrhoea have been shown to be beneficial? International Child Health Review Collaboration, 2006. http://www.ichrc.org/sites/www.ichrc.org/files/ micronutdiar.pdf
22. Grotto I, Mimouni M, Gdalevich M, et al. Vitamin A supplementation and childhood morbidity from diarrhoea and respiratory infections. J Pediatr 2003;142: 297-304.
23. Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, et al. Probiotics for treating persistent diarrhoea in children (Review). Cochrane Database Syst Rev 2010;(11):CD007401.
24. Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010;(11).
25. Faure C. Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children. Int J Pediatr 2013:612403. doi:10.1155/2013/612403.
26. World Health Organisation/United Nations Children's Fund. WHO/UNICEF joint statement on the clinical management of acute diarrhoea. Geneva: WHO/UNICEF, 2004.
27. United Nations Children's Fund (UNICEF)/World Health Organization (WHO). Diarrhoea: why children are still dying and what can be done. Geneva: UNICEF/ WHO, 2009.
28. Sanders D, Doherty T, Mason J, et al. Excellent can be the enemy of the good: the case of diarrhoea management. Correspondence. Lancet 2013;382: 307-8.
29. Bhutta Z, Black RE, Chopra M, et al. Authors' reply. Correspondence. Lancet 2013;382:308.
30. Bhutta ZA, Das JK, Walker N, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Childhood Pneumonia and Diarrhoea 2. Lancet 2013;381: 1417-29.
31. Every Women Every Child. Zinc - Product Profile. Every Women Every Child, 2012.
32. Shah D, Choudhury P, Gupta P, et al. Promoting appropriate management of diarrhoea: a systematic review of literature for advocacy and action: UNICEF-PHFI series on newborn and child health, India. Indian Pediatr 2012;49: 627-49.
33. National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. Bangladesh Demographic and Health Survey 2011. Dhaka, Bangladesh and Calverton, Maryland, USA: NIPORT, Mitra and Associates, and ICF International, 2013.
34. World Health Organisation/United Nations Children's Fund. The Integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Geneva: WHO, 2013.
35. Greco G, Powell-Jackson T, Borghi J, et al. Countdown to 2015: assessment of donor assistance to maternal, newborn, and child health between 2003 and 2006. Lancet 2008;371: 1268-75.
36. World Health Organisation. The Analytic Review of the Integrated Management of Childhood Illness Strategy (IMCI). Geneva: World Health Organisation, 2003.
37. Moran M, Guzman J, Ropars AL, et al. Neglected disease research and development: How much are we Really spending? PLoS Med 2009;6:e1000030.
38. Hudacek DL, Kuruvilla S, Kim N, et al. Analysing media coverage of the Global Fund Diseases compared with lower funded diseases (childhood pneumonia, diarrhoea and measles. PLoS ONE 2011;6:e20438.
39. President's Emergency Plan for AIDS Relief (PEPFAR) Country Operational Plans (COPs) for fiscal years 2007-2011. http://www.pepfar.gov/countries/cop/ (accessed 10 Apr 2013).
40. World Health Organisation. World Malaria Report 2011. http://www.who.int/ malaria/world-malaria-report-2011/en/(accessed 10 Apr 2013).
41. USAID. Introducing Paediatric Zinc with ORT/ORS in the Private Sector. Meeting report. August 2010.
42. Clinton Health Access Initiative. Transforming diarrhoea treatment-A cost-effective opportunity to reduce child mortality. PowerPoint presentation. 2012.
43. Bump JB, Reich MR, Johnson AM. Diarrhoeal diseases and the global health agenda: measuring and changing priority. Health Policy Plan 2012; doi:10.1093/ heapol/czs119 [ published online 27 Nov 2012].
44. Essential Medicines (Diarrhoea and Pneumonia) Working Group. Transforming pneumonia and diarrhoea treatment: A cost-effective opportunity to reduce child mortality. New York, 2013.
45. Essential Medicines (Diarrhoea and Pneumonia) Working Group. Country Updates. New York, 2013.
46. Sabot O, Schroder K, Yamey G, et al. Scaling up oral rehydration salts and zinc for the treatment of diarrhoea. BMJ 2012;344:e940.
47. Harvey P. Cost-effectiveness of zinc supplementation as an adjunct treatment for childhood diarrhoea. USAID Micronutrient Program (MOST) 2005.
48. Horton S, Begin F, Greig A, et al. Best Practice Paper: Micronutrient supplements for child survival (vitamin a and zinc) Working Paper. Copenhagen: Copenhagen Consensus Centre, 2008.
49. Point-of-Use Water Disinfection and Zinc Treatment (POUZN) Project. Introducing Improved Treatment of Childhood Diarrhoea with Zinc and ORT in India, Indonesia, and Tanzania: a Public-Private Partnership Supported by the POUZN/AED Project. Washington, DC: United States Agency for International Development (USAID), 2011.
50. Stene A, MacDonald V, Mitchell S, et al. Social Marketing Plus for Diarrheal Disease control: Point-of-use Water Disinfection and Zinc treatment (POUZN) Project 2005-2010 final report. Abt Associates Inc., 2010.
51. Fischer Walker CL, Friberg IK, Binkin N, et al. Scaling up diarrhoea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med 2011;8: 1-10.
52. Hill S, Yang A, Bero L. Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists. PLoS ONE 2012;7:e38055.
53. Every Women Every Child. Oral Rehydration Salts (ORS)-Product Profile. Every Women Every Child 2012.
54. Larson CP, Koehlmoos TP, Sack DA. Scaling up zinc treatment of childhood diarrhoea in Bangladesh: Theoretical and practical considerations guiding the SUZY Project. Health Policy Plan 2011;27: 102-14.
55. University of Washington Global Health START Program. Nepal Zinc Case Study. 2013.
56. Point-of-Use Water Disinfection and Zinc Treatment (POUZN) Project. Introducing Improved Treatment of Childhood Diarrhea With Zinc and ORT in India, Indonesia, and Tanzania: A Public-Private Partnership Supported by the POUZN/AED Project. Washington, DC: United States Agency for International Devleopment (USAID), 2011.
57. Gitanjali B, Weerasuriya K. The curious case of zinc for diarrhoea: Unavailable, unprescribed, and unused. J Pharmacol Pharmacother. 2011;2: 225-9.
58. United States Agency for International Development (USAID). Zinc Supplementation for the Treatment of Diarrhea: Moving from Research to Practice. USAID Micronutrient Program (MOST).
59. Kaplan W, Laing R. Local production of pharmaceuticals: Industrial policy and access to medicines. An overview of key concepts, issues and opportunities for future research. Health, Nutrition and Population Discussion Paper. Washington, DC: World Bank Human Development Network, 2005.
60. Fake Pharmaceuticals: Bad Medicine. The Economist. Washington, DC, 2012.
61. Harper J, Gyansa-Lutterodt M. The Viability of Pharmaceutical Manufacturing in Ghana to Address Priority Endemic Diseases in the West Africa Sub-region. Trade Related Aspects of Intellectual Property Rights (TRIPS). Eschborn, Germany: German Federal Ministry for Economic Cooperation and Development (GTZ), 2007.
62. Wilson S, Morris S, Gilbert S. Zinc Case Study Tanzania. Bill & Melinda Gates Foundation, 2012.
63. Chowdhury AMR, Cash RA. A Simple Solution: Teaching millions to treat diarrhoea at home [Hardcover]. Dhaka: University Press Limited, 1966.
64. Kinder M. Case 8: Preventing Diarrhoeal Deaths in Egypt. Washington, DC: Centre for Global Development, 2005.
65. USAID. Introducing Zinc Through the Private Sector in Nepal for the Treatment of Diarrhoea: Results and Lessons Learned. Point-of-Use Water Disinfection and Zinc Treatment (POUZN) Project. Washington, DC, 2009.
66. Ellis AA, Winch P, Daou Z, et al. Home management of childhood diarrhoea in southern Mali-Implications for the introduction of zinc treatment. Soc Sci Med 2007;64: 701-12.
67. Baqui AH, Black RE, El Arifeen S, et al. Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children. J Health Popul Nutr 2004;22: 440-2.
68. Bill and Melina Gates Foundation. Gates Award for Global Health. 2001.
69. Roy SK, Tomkins AM, Mahalanabis D, et al. Impact of zinc supplementation on persistent diarrhoea in malnourished Bangladeshi children. Acta Pædiatrica 1998;87. http://dx.doi.org/10.1111/j.1651-2227.1998.tb00943.x (accessed 30 Jan 2013).
70. Roy SK, Tomkins AM, Akramuzzaman SM, et al. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child 1997;77: 196-200.
71. Alam DS, Yunus M, El Arifeen S, et al. Zinc treatment for 5 or 10 days is equally efficacious in preventing diarrhoea in the subsequent 3 months among Bangladeshi children. J Nutr 2011;141: 312-15.
72. Naheed A, Walker Fischer CL, Mondal D, et al. Zinc therapy for diarrhoea improves growth among Bangladeshi infants 6 to 11 months of age. J Pediatr Gastroenterol Nutr 2009;48: 89-93.
73. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 615-23.
74. Zaman K, Yunus M, El Arifeen S, et al. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh. Vaccine 2012;30:A94-100.
75. Zaman K, Sack DA, Yunus M, et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009;27: 1333-9.
76. United Nations Children Fund (UNICEF). Child Info. Statistics by Country. 2010. http://www.childinfo.org/country-list.php (accessed 23 Aug 2013).